Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DFQ17Y
|
|||
| Drug Name |
TMB-365
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1 | [1] | |
| Company |
TaiMed Biologics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04027387) Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of TaiMed Biologics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.